+

WO2002002771A3 - Human sparc-homologous (hsparc-h1) gene and methods and uses thereof - Google Patents

Human sparc-homologous (hsparc-h1) gene and methods and uses thereof Download PDF

Info

Publication number
WO2002002771A3
WO2002002771A3 PCT/US2001/014859 US0114859W WO0202771A3 WO 2002002771 A3 WO2002002771 A3 WO 2002002771A3 US 0114859 W US0114859 W US 0114859W WO 0202771 A3 WO0202771 A3 WO 0202771A3
Authority
WO
WIPO (PCT)
Prior art keywords
hsparc
methods
homologous
gene
human sparc
Prior art date
Application number
PCT/US2001/014859
Other languages
French (fr)
Other versions
WO2002002771A2 (en
Inventor
Pamela Jean Mitchell
Rosamund Carol Smith
Eric Wen Su
Original Assignee
Lilly Co Eli
Pamela Jean Mitchell
Rosamund Carol Smith
Eric Wen Su
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Pamela Jean Mitchell, Rosamund Carol Smith, Eric Wen Su filed Critical Lilly Co Eli
Priority to AU2001268053A priority Critical patent/AU2001268053A1/en
Publication of WO2002002771A2 publication Critical patent/WO2002002771A2/en
Publication of WO2002002771A3 publication Critical patent/WO2002002771A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to at least one novel hSPARC-h1 polypeptide, isolated nucleic acids that encode such hSPARC-h1 polypeptides, as well as vectors, host cells, transgenics, chimerics, methods of making and using thereof, and hSPARC-h1 antibodies and uses thereof.
PCT/US2001/014859 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof WO2002002771A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001268053A AU2001268053A1 (en) 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21621600P 2000-07-05 2000-07-05
US60/216,216 2000-07-05

Publications (2)

Publication Number Publication Date
WO2002002771A2 WO2002002771A2 (en) 2002-01-10
WO2002002771A3 true WO2002002771A3 (en) 2003-01-23

Family

ID=22806217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/014859 WO2002002771A2 (en) 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Country Status (2)

Country Link
AU (1) AU2001268053A1 (en)
WO (1) WO2002002771A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5568208B2 (en) 2003-01-14 2014-08-06 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Cancer treatment sensitizer
US8420603B2 (en) 2004-05-14 2013-04-16 Abraxis Bioscience, Llc SPARC and methods of use thereof
AU2006249235B2 (en) 2004-05-14 2010-11-11 Abraxis Bioscience, Llc Sparc and methods of use thereof
WO2017070744A1 (en) * 2015-10-30 2017-05-04 Monash University Methods and compositions for improving glucose metabolism
US20210262006A1 (en) * 2018-06-18 2021-08-26 Emory University Parallel Enzyme Digestion for Protein Biomarker Detection
US11691208B2 (en) 2018-10-27 2023-07-04 Ridge Tool Company Pipe cut-off tool and accessories for such tools

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (en) * 1998-05-14 1999-11-18 Chiron Corporation Human genes and gene expression products v
WO2000061755A2 (en) * 1999-04-09 2000-10-19 Chiron Corporation Secreted human proteins
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001060850A1 (en) * 2000-02-14 2001-08-23 Smithkline Beecham Corporation Novel compounds
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002002603A2 (en) * 2000-06-30 2002-01-10 Incyte Genomics, Inc. Protein modification and maintenance molecules

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (en) * 1998-05-14 1999-11-18 Chiron Corporation Human genes and gene expression products v
WO2000061755A2 (en) * 1999-04-09 2000-10-19 Chiron Corporation Secreted human proteins
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001060850A1 (en) * 2000-02-14 2001-08-23 Smithkline Beecham Corporation Novel compounds
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002002603A2 (en) * 2000-06-30 2002-01-10 Incyte Genomics, Inc. Protein modification and maintenance molecules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 July 1999 (1999-07-01), XP002205641, Database accession no. AF070470 *
MOTAMED K: "SPARC (osteonectin/BM-40).", THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, vol. 31, no. 12, December 1999 (1999-12-01), pages 1363 - 1366, XP002205640, ISSN: 1357-2725 *

Also Published As

Publication number Publication date
WO2002002771A2 (en) 2002-01-10
AU2001268053A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
WO2004003147A3 (en) Cngh0004 polypeptides, antibodies, compositions, methods and uses
WO1998056927A3 (en) Nucleic acids encoding polypeptide having protease activity
WO2001046420A8 (en) Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
WO1999061469A3 (en) Prostate growth-associated membrane proteins
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
WO2002006457A3 (en) Novel lipase genes
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2002062999A3 (en) Proteins and nucleic acids encoding same
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2002046409A3 (en) Proteins and nucleic acids encoding same
WO2002036627A3 (en) Interferons, uses and compositions related thereto
WO2001098469A3 (en) Polypeptides having peroxidase activity and nucleic acids encoding same
WO2001090326A3 (en) Novel matrix metalloproteinases
WO2002016611A3 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
WO2003057821A3 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2002085922A3 (en) Proteins and nucleic acids encoding same
WO2001092493A3 (en) 21956 and 25856, human aminopeptidases and uses thereof
WO2000039297A3 (en) Il-1 related polypeptides
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2001083552A3 (en) Human sez6 nucleic acids and polypeptides
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002048187A3 (en) Secretion signal peptides, their dna sequences, expression vectors for eukaryotic cells that can be produced with the same, and use thereof for biotechnological production of proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载